Test III Flashcards
(82 cards)
Bacterial Genome
- Usually 1 circular chromosome
- 4-5 Mb of DNA
- Tightly packed, DNA molecule condenses by supercoiling and looping
- Each bacterium replicates and then divides by binary fission into 2 daughter cells.
- Prokaryotes are haploid
- Often contain plasmids
- Only circular DNA molecules in prokaryotes replicate
Eukaryote genomes
- Diploid
- Linear chromosome, usually more than one
Plasmid
- Small circles of double stranded DNA
- Used as cloning vectors
- May contain genes that benefit host bacterium or contribute to bacterial pathogenicity
Resistance plasmids
- Contain transposons
- Carry genes tat confer resistances to multiple antibiotics
- Can be transferred from one bacterium to another in nature
Prokaryote genomes
- More than 80% of the chromosomal fraction is dedicated to protein coding genes required for growth and metabolic functions
- 1% encodes RNA specifying genes
- The rest comprises intergenic spacers containing regulatory signals
Microbial variation
- In comparison to eukaryotes, genome sizes in singled celled organisms varies very little
- But bacterial display big variation in metabolic properties, cellular structures and lifestyles
- Phenotypic diversity among species is remarkable
- However organisational features of the genome are very well conserved
Organisation of microbial genome
- Many cellular processes within bacterial are coupled
- Genes within bacteria are usually co transcribed
- Genes are arranged in OPERONS
- Functioning unit of genomic DNA containing a cluster of genes under the control of a single regulatory signal or promoter
- The genes are transcribed together in an mRNA strand
- Genes contained in the operon are either expressed together of not at all
Gene transfer in Bacteria:
Vertical gene transfer
- occurs in sexually reproducing organisms
- traits are transferred from parent to offspring
Horizontal gene transfer
-Traits are introduced from unrelated individuals or from different species
Three mechanism for gene transfer in bacteria. In all three mechanisms..
- Donor bacterium provides the DNA that is transferred
- Recipient bacterium receives the DNA, which results in altered phenotype
Transformation
- Lysis of donor cell releases DNA into medium
- Donor DNA is taken up by the recipient
- Process by which a DNA molecule is taken up from the external environment and incorporated into the genome of the recipient cell.
Conjugation
- Donor DNA is transferred directly to recipient through a connecting tube.
- Contact and transfer are promoted by a specialised plasmid in the donor cell.
- Temporary direct contact between two bacterial cells leading to an exchange of genetic material (DNA).
- This exchange is unidirectional, i.e. one bacterial cell is the donor of DNA and the other is the recipient.
- In this way, genes are transferred laterally amongst existing bacterial as opposed to vertical gene transfer in which genes are passed on to offspring.
Transduction
- Bacteriophage infects a cell
- Lysis of donor cell. Donor DNA is packaged in released bacteriophage
- Donor DNA is transferred when phage particles infects recipient cell.
- Involves transfer genetic material from one bacterium to another by a bacteriophage.
- Acting as a vector, the virus carries its own genome plus a fragment of DNA from the bacterium it has recently infected. If the host bacterium survives the viral attack, recombination may occur,
Personalised Medicine
- Individual respond differently to drugs and sometimes the effects are unpredictable
- Differences in DNA that alter the expression or function of proteins that are targeted by drugs can contribute significantly to variation in the responses of individual
- Genome based information and technologies may yield a new set of molecular diagnostic tools that can be used to individualise and optimise drug therapy
The goal of Personalised Medicine
- The right dose…
- The right drug for….
- The right indication for….
- The right patient for at…
- The right time…
Walfarin
- Multisource anticoagulant (different strength tablets)
- Walfarin inhibits vitamin K reductase, which is the enzyme responsible for recycling oxidated vitamin K back into the system. For this reason, drugs in this class are also called vitamin K antagonists.
Walfarin doses
Narrow therapeutic Index
-small separation between dose response curves for prevent ing emboli and excess coagulation
Non linear dose response (INR)
-small changes in dose may cause changes in INR with a time lag
Wide ranges of doses to achieve target INR of 2-3
Walfarin Metabolism
- 2 polymorphic genes, CYP2C9 and VKORC1 affect walfarin metabolism and response
- Allelic frequencies of these two genes are usually associated with ethnicity
Concerns with prescribing patients with the 2 polymorphisms
- overdose can result in bleeding which can be fatal
- underdose can thrombosis which can be fatal
CYP2P9 is involved in walfarin metabolism
VKORC1 influences walfarin anticoagulation effect through vitamin K
Influenze Subgroups
Influenza A
- highly infective
- infects many species
- causes widespread epidemics (pandemic)
Influenza B
- found in humans
- capable of producing severe disease
- causes regional epidemics
Influenza C
- causes mild disease
- humans are natural host, but also found in pigs
- does not cause epidemics
Reasons for pandemics
- New flu virus occurs due to a process involving mutation and recombination of viral genomes
- Mutations can occur in the replication process of the viral genome
- Mixing occurs because different strains of influenza virus can exchange genes by infecting different animals
- Avian influenza viruses can exchange genes with human influenza viruses creating hybrid stains
Influenza Virus genome
- RNA virus
- The genome consist of 7-8 RNA fragments, each coding for a viral protein
- 8 genes are responsible for the translation of 10-11 viral proteins.
PB2-transcriptase: cap binding
HA: Haemagglutinin
Na: Neuraminidase: release of virus
Influenza virus structure
- Nucleocapsid: RNA enclosed in a protein coat
- Surrounded by a lipid envelope
- Two glycoproteins present: HA and NA
Influenza Virus Lifecycle
- HA binds to cell GP at a Sialic Acid binding site
- Clathrin-coated pit endocytoses virion
- Conformational change: hydrophobic binding of HA to vesicle membrane - RNAs are released into cytoplasm for replication and transcription (vRNA and mRNA)
Neuraminidase
- Allows release of the newly formed viruses within the host
- Determinant of disease severity
Release of Newly Formed Viruses
- Replicated vRNA, RNA replicases and other viral proteins are assembled into virions
- HA and NA cluster into a cell membrane bulge
- Virion leaves the nucleus and enters the membrane protrusion
- Mature virus buds from cell in host membrane containing HA and NA
- HA binding virus to cell surface via receptors containing sialic acid
- NA cleaves receptors allowing release of virus